<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">338</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2025.6.2.77-81</article-id>
<title-group><article-title>The Clinical, Subclinical Characteristics and the Factor Associated of Intrauterine Fetal Death at ≥14 Weeks of Pregnancy</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><name><surname>Nga</surname><given-names>Mai Thi</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Thu</surname><given-names>Tran</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Trinh</surname><given-names>Nguyen Khanh</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Phong</surname><given-names>Trieu Le</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<aff id="aff1"><label>1</label>Buon Ma Thuot Medical University - 298, Ha Huy Tap, Buôn Ma Thuot city, Dak Lak province, Vietnam</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><year>2025</year></pub-date>
<volume>6</volume>
<issue>2</issue>
<fpage>77</fpage>
<lpage>81</lpage>
<history>
<date date-type="received"><day>14</day><month>03</month><year>2025</year></date>
<date date-type="accepted"><day>17</day><month>04</month><year>2025</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/338/the-clinical-subclinical-characteristics-and-the-factor-associated-of-intrauterine-fetal-death-at"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/338/download"/>
<abstract><p>The study carried out on 84 women with intrauterine fetal death at ≥14 weeks of pregnancy hospitalized at obstetrics and gynecology department in Tay Nguyen Regional General Hospital from 1/2024 to 12/2024. The average age of pregnant women is 30,5 ± 8,3 years old, 60,7% of cases were multiparous pregnancy. The average age of stillbirth was 28,7 ± 9,2 weeks. 40,5% of pregnant women detect stillbirth because of abdominal pain or vaginal bleeding, 38,1% because the fetus was not moving, and 21,4% discovered the stillbirth during a periodic prenatal examination. 59,5% had regular check-ups during pregnancy. 14% case of them detected abnormalities. In the second trimeste, abnormalities detected during prenatal check-ups are usually related to fetal malformations, while in the third trimester, most abnormalities are associated with the placenta, umbilical cord, and amniotic fluid (p</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Intrauterine Fetal Death</kwd><kwd>Clinical</kwd><kwd>Subclinical</kwd><kwd>Factor Associated</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Ministry of Health. Intrauterine fetal death. National guidelines on reproductive health services. 2016:125–7.</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>The Lancet Ending Preventable Stillbirths Study Group. Ending preventable stillbirths. Lancet. 2016.</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Man J, Hutchinson JC, Heazell AE, et al. Stillbirth and intrauterine fetal death: factors affecting determination of cause of death at autopsy. Ultrasound Obstet Gynecol. 2016;48(5):566–73. [Translation not a reference, omitted.]</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Vo Thi Thanh Thanh. Evaluation of the effectiveness of misoprostol in the management of first-trimester intrauterine fetal death [Medical Doctor thesis]. Hue: Hue University of Medicine and Pharmacy; 2021.</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Amin KV, Chauhan AR, Goel A. Current practices of cervical ripening and induction of labour in intrauterine foetal demise: an observational study. J Obstet Gynaecol India. 2019;69(1):37–42.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Sharma B, Bhattarai S, Shrestha S, et al. Maternal and fetal characteristics and causes of stillbirth in a tertiary care hospital of Nepal: secondary analysis of registry-based surveillance data. BMJ Open. 2021;11(8):e045012.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Pham Thi Linh, Truong My Ngoc, Le Thi My Tien. Evaluation of the outcomes of pregnancy termination with misoprostol at 13 to 22 weeks of gestation at Can Tho City Obstetrics Hospital. Can Tho: Can Tho City Obstetrics Hospital; 2018.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Vo Thi Thanh Huyen. Evaluation of the effectiveness of misoprostol in the management of first and second trimester intrauterine fetal death [Specialist Level II thesis]. Hue: Hue University of Medicine and Pharmacy; 2024.</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Aminu M, Bar-Zeev S, White S, et al. Understanding cause of stillbirth: a prospective observational multi-country study from sub-Saharan Africa. BMC Pregnancy Childbirth. 2019;19(1):470.</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Muin DA, Scharrer A, Farr A, et al. Timing of hospital admission for stillbirth delivery on maternal and obstetric outcome: a retrospective cohort study. Sci Rep. 2021;11(1):18854.</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Patel M, Shah A, Patel NM, Patel MR, Patel KR. Nano suspension: a novel approach delivery system for drug. JPSBR. 2011;1(1):1–10. International Journal of Medical and All Body Health Research www.allmedicaljournal.com</mixed-citation></ref>
<ref id="R12"><label>12</label><mixed-citation>Haranath C, Reddy JL, Ahad HA, Reshma T, Shubha BN. Aquasomes: a novel approach for the delivery of bioactive molecules. J Med Pharm Allied Sci. 2022;11:5325–30.</mixed-citation></ref>
<ref id="R13"><label>13</label><mixed-citation>Eltahir AK, Ahad HA, Haranath C, Meharajunnisa B, Dheeraj S, Sai BN. Novel phytosomes as drug delivery systems and its past decade trials. Res J Pharm Dosage Forms Technol. 2023;15(1):51–4.</mixed-citation></ref>
<ref id="R14"><label>14</label><mixed-citation>Bhati R, Nagrajan RK. A detailed review on oral mucosal drug delivery system. Int J Pharm Sci Res. 2012;3(1):659–81.</mixed-citation></ref>
<ref id="R15"><label>15</label><mixed-citation>Mubarak ZO. An overview on buccal drug delivery system. SunText Rev Pharm Sci. 2021;2(1):1–6.</mixed-citation></ref>
<ref id="R16"><label>16</label><mixed-citation>Haranath C, Poojitha N, Ahad HA, Yarra S, Eranti B. Recent advances in lipid based nanovesicles for transdermal drug delivery. J Med Pharm Allied Sci. 2022;11(6):5217–20.</mixed-citation></ref>
<ref id="R17"><label>17</label><mixed-citation>Singh RP, Parpani S, Narke R, Chavan R. Emulgel: a recent approach for topical drug delivery system. Asian J Pharm Res Dev. 2014;2(2):112–23.</mixed-citation></ref>
<ref id="R18"><label>18</label><mixed-citation>Vani YB, Haranath C, Reddy CS, Bhargav E. Formulation and in vitro evaluation of piroxicam emulgel. Int J Pharm Sci Drug Res. 2018;10(4):227–32.</mixed-citation></ref>
<ref id="R19"><label>19</label><mixed-citation>Mohammed Haneefa KP, Easo S, Hafsa PV, Mohanta GP, Nayar C. Emulgel: an advanced review. J Pharm Sci Res. 2013;5(12):254–8.</mixed-citation></ref>
<ref id="R20"><label>20</label><mixed-citation>Sultana F, Manirujjaman, Imran-Ul-Haque M, Arafat M, Sharmin S. An overview of nanogel drug delivery system. J Appl Pharm Sci. 2013;3(8-1):S95–S105.</mixed-citation></ref>
<ref id="R21"><label>21</label><mixed-citation>Zarekar NS, Lingayat VJ, Pande VV. Nanogel as a novel platform for smart drug delivery system. Nanosci Nanotechnol Res. 2017;4(1):25–31.</mixed-citation></ref>
<ref id="R22"><label>22</label><mixed-citation>Abdul AH, Bala AG, Chintaginjala H, Manchikanti SP, Kamsali AK, Dasari RR. Equator assessment of nanoparticles using the design-expert software. Int J Pharm Sci Nanotechnol. 2020;13(1):4766–72.</mixed-citation></ref>
<ref id="R23"><label>23</label><mixed-citation>Wang H, Chen Q, Zhou S. Carbon-based hybrid nanogels: a synergistic nanoplatform for combined biosensing, bioimaging, and responsive drug delivery. Chem Soc Rev. 2018;47:4198–232.</mixed-citation></ref>
<ref id="R24"><label>24</label><mixed-citation>Muthal AD, Kshirsagar SJ, Bhambere DS, Patil MP, Ahhirao SS, Vishwakarm RP. A brief overview of nanogel. World J Pharm Res. 2022;11(4):1922–42.</mixed-citation></ref>
</ref-list></back>
</article>